机构:[1]Institute of Vascular Medicine, Cardiology Department, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptide, Ministry of Health, and Beijing Key Laboratory of Cardiovascular Receptors Research, No. 49, Huayuan Bei Road, Haidian District, Beijing 100191, China[2]Vascular Biology Department, Beijing AnZhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Institute of Heart, Lung and Blood Vessel Diseases, No.2, Anzhen Road, Chaoyang District, Beijing 100029, China首都医科大学附属安贞医院[3]Department of Nephrology, Jiangsu Key Laboratory of Pediatrics, Children’s Hospital of Nanjing Medical University, No.140, Hanzhong Road, Nanjing, Jiangsu Province 210008, China[4]Department of Pharmacology, Emory University School of Medicine, 5029 Rollins Research Center, 1510 Clifton Road, Atlanta, GA 30322, USA
National Natural Science Foundation of China (81530009 and 81030001 to Y.Y.Z.), (81670205 and 81300067 to H. X.); National Basic Research Program of China (2012CB518000 to Y.Y.Z.); and Clinical key Project of Peking University Third Hospital (BYSY2014021 to H. X.).
语种:
外文
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|1 区医学
小类|1 区心脏和心血管系统
最新[2023]版:
大类|1 区医学
小类|1 区心脏和心血管系统
第一作者:
第一作者机构:[1]Institute of Vascular Medicine, Cardiology Department, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptide, Ministry of Health, and Beijing Key Laboratory of Cardiovascular Receptors Research, No. 49, Huayuan Bei Road, Haidian District, Beijing 100191, China
共同第一作者:
通讯作者:
通讯机构:[1]Institute of Vascular Medicine, Cardiology Department, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptide, Ministry of Health, and Beijing Key Laboratory of Cardiovascular Receptors Research, No. 49, Huayuan Bei Road, Haidian District, Beijing 100191, China
推荐引用方式(GB/T 7714):
Han Xiao,Hao Li,Jing-JingWang,et al.IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-Adrenergic insult[J].European Heart Journal.2018,39(1):60-69.doi:10.1093/eurheartj/ehx261.
APA:
Han Xiao,Hao Li,Jing-JingWang,Jian-Shu Zhang,Jing Shen...&You-Yi Zhang.(2018).IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-Adrenergic insult.European Heart Journal,39,(1)
MLA:
Han Xiao,et al."IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-Adrenergic insult".European Heart Journal 39..1(2018):60-69